EP EMPOWERPHARM Trademark

Trademark Overview


On Tuesday, March 26, 2019, a trademark application was filed for EP EMPOWERPHARM with the United States Patent and Trademark Office. The USPTO has given the EP EMPOWERPHARM trademark a serial number of 88356979. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, June 28, 2023. This trademark is owned by EmpowerPharm Inc.. The EP EMPOWERPHARM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, naproxen sodium, acetaminophen, cold, sore throat and cough medications, guaifenesin, liquid cough medicines with dextromethorphan, decongestant nasal sprays, pseudoephedrine, phenylephrine, allergy medications, antihistamine pills and liquids, diphenhydramine, chlorpheniramine, brompheniramine, loratadine, fexofenadine, cetirizine, stomach upset medications, antidiarrhea medicines, loperamide, bismuth, nausea and vomiting, motion sickness, dimenhydrinate; cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis in the form of lotions, skin creams for topical medicinal use; creams, ointments, skin patches, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more th...
ep empowerpharm

General Information


Serial Number88356979
Word MarkEP EMPOWERPHARM
Filing DateTuesday, March 26, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, June 28, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the term "EMPOWERPHARM" and to the left of the term is a stylized design composed of the letters "E" and "P".
Goods and ServicesPharmaceutical preparations, namely, nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, naproxen sodium, acetaminophen, cold, sore throat and cough medications, guaifenesin, liquid cough medicines with dextromethorphan, decongestant nasal sprays, pseudoephedrine, phenylephrine, allergy medications, antihistamine pills and liquids, diphenhydramine, chlorpheniramine, brompheniramine, loratadine, fexofenadine, cetirizine, stomach upset medications, antidiarrhea medicines, loperamide, bismuth, nausea and vomiting, motion sickness, dimenhydrinate; cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis in the form of lotions, skin creams for topical medicinal use; creams, ointments, skin patches, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Pseudo MarkE P EMPOWER PHARM
Pseudo MarkEP EMPOWER PHARM
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEmpowerPharm Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, Ontario L7L6M1
CA

Trademark Events


Event DateEvent Description
Wednesday, June 28, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, June 28, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, June 28, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 10, 2022NON-FINAL ACTION E-MAILED
Thursday, November 10, 2022NON-FINAL ACTION WRITTEN
Thursday, November 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 10, 2022NON-FINAL ACTION E-MAILED
Thursday, November 10, 2022NON-FINAL ACTION WRITTEN
Thursday, October 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 19, 2022ASSIGNED TO LIE
Friday, September 9, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 14, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, March 14, 2022INQUIRY TO SUSPENSION E-MAILED
Monday, March 14, 2022SUSPENSION INQUIRY WRITTEN
Monday, February 14, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, February 7, 2022ASSIGNED TO EXAMINER
Tuesday, July 6, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, April 28, 2021ASSIGNED TO EXAMINER
Monday, July 27, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 27, 2020LETTER OF SUSPENSION E-MAILED
Monday, July 27, 2020SUSPENSION LETTER WRITTEN
Tuesday, July 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 4, 2020NON-FINAL ACTION E-MAILED
Wednesday, March 4, 2020NON-FINAL ACTION WRITTEN
Friday, February 28, 2020ASSIGNED TO EXAMINER
Monday, April 15, 2019ASSIGNED TO EXAMINER
Thursday, April 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 29, 2019NEW APPLICATION ENTERED